Cafepharma Today

April 17 2024 - Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Lilly eyes Zepbound label expansion after clearing phase III sleep apnea study
3 patent expirations in 2024 and how companies are pivoting
Abbott beats Wall Street expectations with med device sales, raises outlook
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Synergy Pharma shoots higher on plecanatide plans
Yahoo/AP
Thursday, November 15, 2012 - 11:59am
tags:
plecanatide, Synergy Pharmaceuticals
After The Bloodbath, Where Does Pharmacyclics Go From Here?
Seeking Alpha
Thursday, November 15, 2012 - 11:58am
tags:
Pharmacyclics, earnings
MAP Pharma's Awkward FDA Silence
TheStreet.com
Thursday, November 15, 2012 - 11:57am
tags:
FDA, MAP Pharmaceuticals, migraines, Levadex
Upstart Valor launches with plans to develop armed antibody cancer drugs
Fierce Biotech
Thursday, November 15, 2012 - 11:35am
tags:
Valor, armed-antibodies, cancer
Tranzyme Stomach Paralysis Drug Comes Up Short
TheStreet.com
Thursday, November 15, 2012 - 11:33am
tags:
stomach paralysis, Tranzyme
Alnylam: No Approved Drugs, No Promising Candidates, No Justification For $1 Billion Valuation
Seeking Alpha
Thursday, November 15, 2012 - 11:32am
tags:
Alnylam
J&J, Lilly, Merck plan clinical trial site database
Reuters
Thursday, November 15, 2012 - 11:13am
tags:
JNJ, Eli Lilly, Merck, clinical trials
Gilead's single tablet Stribild shows positive results in two HIV studies
Yahoo/Fly on the Wall
Thursday, November 15, 2012 - 11:11am
tags:
HIV, Stribild, Gilead
Merck KGaA expects to publish Stimuvax data in Q1 2013
Reuters
Thursday, November 15, 2012 - 11:09am
tags:
Merck KGaA, Stimuvax, vaccines, cancer, Oncothyreon
Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis
Yahoo
Thursday, November 15, 2012 - 11:06am
tags:
baricitinib, Incyte, JAK inhibitors, Eli Lilly, rheumatoid arthritis
The Other Side Of Galena Biopharma
Seeking Alpha
Thursday, November 15, 2012 - 11:06am
tags:
Galena Biopharma
GlaxoSmithKline says FDA panel recommends approval of H5N1 flu vaccine
The Fly on the Wall
Thursday, November 15, 2012 - 10:57am
tags:
FDA, advisory panels, H5N1, vaccines, GSK
Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients
Bloomberg
Thursday, November 15, 2012 - 10:53am
tags:
GSK, Pfizer, HIV, Dolutegravir, Shionogi
How To Reach Those Hard-To-Reach Docs
Pharmalot
Thursday, November 15, 2012 - 10:50am
tags:
physicians, drug reps
Merck - How To Play This 'Patent Cliff' With Options
Seeking Alpha
Thursday, November 15, 2012 - 10:49am
tags:
patent cliff, Merck, Singulair, Odanacatib, Maxalt, MK-3475
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thursday, November 15, 2012 - 10:47am
tags:
Teva, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Merck, Novo Nordisk, Novartis, Pfizer, Sanofi
Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union
Yahoo/AP
Thursday, November 15, 2012 - 10:46am
tags:
diabetes, Bristol-Myers Squibb, AstraZeneca, Europe, SGLT2 inhibitor, Forxiga
Who Will Pioneer the New Diabetes Market?
Motley Fool
Thursday, November 15, 2012 - 10:45am
tags:
diabetes, JNJ, Merck, Bristol-Myers Squibb, AstraZeneca, SGLT2 inhibitor
3 Potential Partners for Amarin
Motley Fool
Thursday, November 15, 2012 - 10:43am
tags:
M&A, Amarin, AstraZeneca, Merck, Eli Lilly
Genzyme resolves shortage of cancer drug Thyrogen
Fierce Pharma
Wednesday, November 14, 2012 - 12:38pm
tags:
Thyrogen, Genzyme, thyroid cancer

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels
Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)
Drug Channels

Latest Jobs

Pharmaceutical Sales- Associate Territory Manager- Primary Care
Washington DC, 20066
Eli Lilly and Company
Sales Representative
Nampa, ID, 83651
Bartlett Roofing
Pharmaceutical Sales Representative (PSR)
Iowa City, IA, 52246
Syneos Health, Inc
Diagnostics Hematology Specialist (Michigan)
Michigan, ND, 58259
Adaptive Biotechnologies
Professional Pharmaceutical Sales Representative
Pueblo, CO, 81001
Syneos Health, Inc
Pharmaceutical Sales- Associate Territory Manager- Primary Care
Covington, Georgia
Eli Lilly and Company
Manager, Inside Sales
Austin, TX
AbbVie
Vice President of Sales
Durham, NC
Confidential
Aesthetic Surgical Rep -Allergan Aesthetics, Richmond/Virginia Beach, VA
Richmond, VA, 23234
AbbVie, Inc
Generic Pharmaceuticals Inside Sales Representative
Cincinnati, OH, 45201
BluPax Pharma
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information